The Magnificent Seven's best days are not behind them, Jim Cramer says
1. Cramer believes the Magnificent Seven, including Apple, will continue succeeding. 2. Strong management and abundant cash support their robust market positions. 3. Apple's Watch has FDA approval to measure hypertension, enhancing product utility. 4. Critics believe gains are over, but Cramer sees ongoing opportunities. 5. The Magnificent Seven's scale makes them resilient to competition and government pressure.